BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21760605)

  • 1. FSGS lesions in IgA nephropathy.
    Fogo AB; Alpers CE; D'Agati VD
    Kidney Int; 2011 Aug; 80(3):319; author reply 319-20. PubMed ID: 21760605
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
    El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
    Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
    Cook HT
    Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL; Rose CL; Magil AB
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
    Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
    Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired glomerular lesions in patients with Down syndrome.
    Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
    Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenic Mechanisms of the Focal Segmental Glomerulosclerosis and Its Role in the Progression of IgA Nephropathy].
    Chen ZJ; Li C; Li H; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Aug; 40(4):549-555. PubMed ID: 30193611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vessel sclerosis and progression in IgA nephropathy.
    Feiner HD; Galvin S; Neelakantappa K; Baldwin D; Gallo GR
    Contrib Nephrol; 1984; 40():222-7. PubMed ID: 6499453
    [No Abstract]   [Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis: cellular variant and beyond.
    Nair R
    Kidney Int; 2006 Nov; 70(10):1676-8. PubMed ID: 17080157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS.
    Wang M
    Nat Rev Nephrol; 2024 Jan; 20(1):6. PubMed ID: 38012264
    [No Abstract]   [Full Text] [Related]  

  • 14. Wegener's granulomatosis, microscopic polyarteritis and pauciimmune crescentic necrotizing glomerulonephritis, an overview.
    Ritz E; Andrassy K; Küster S; Waldherr R
    Przegl Lek; 1992; 49(1-2):6-9. PubMed ID: 1360686
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis.
    Miyata J; Takebayashi S; Taguchi T; Naito S; Harada T
    Nephron; 1986; 44(2):115-20. PubMed ID: 3534606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-seven children with focal segmental glomerulosclerosis: correlation between the segmental location of the glomerular lesions and prognosis.
    Ito H; Yoshikawa N; Aozai F; Hazikano H; Sakaguchi H; Akamatsu R; Matsuo T; Matsuyama S
    Clin Nephrol; 1984 Jul; 22(1):9-14. PubMed ID: 6478668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular disease recurrence in second and subsequent kidney transplants.
    Kennedy C; Obilana A; O'Brien F; O'Kelly P; Dorman A; Denton M; Magee C; Conlon P
    Clin Nephrol; 2013 Jan; 79(1):31-6. PubMed ID: 23073068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)].
    Pani A
    G Ital Nefrol; 2010; 27(6):563. PubMed ID: 21132634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glomerular lesions in adult patients].
    Colombat M; Deleuze S; Callard P
    Nephrol Ther; 2008 Dec; 4(7):617-27. PubMed ID: 18436496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.